 Robert Ryu
Concepts (459)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 19 | 2018 | 50 | 5.510 |
Why?
| | Liver Neoplasms | 60 | 2014 | 509 | 4.070 |
Why?
| | Embolization, Therapeutic | 41 | 2014 | 177 | 3.380 |
Why?
| | Carcinoma, Hepatocellular | 41 | 2014 | 213 | 3.100 |
Why?
| | Yttrium Radioisotopes | 39 | 2014 | 51 | 2.900 |
Why?
| | Device Removal | 13 | 2018 | 127 | 2.810 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 7 | 2019 | 38 | 1.950 |
Why?
| | Radiography, Interventional | 17 | 2016 | 110 | 1.790 |
Why?
| | Radiology, Interventional | 5 | 2019 | 27 | 1.770 |
Why?
| | Pulmonary Embolism | 9 | 2018 | 183 | 1.750 |
Why?
| | Chemoembolization, Therapeutic | 21 | 2014 | 47 | 1.690 |
Why?
| | Hypertension, Portal | 5 | 2016 | 61 | 1.410 |
Why?
| | Radiopharmaceuticals | 18 | 2014 | 165 | 1.230 |
Why?
| | Lumbar Vertebrae | 3 | 2020 | 211 | 1.180 |
Why?
| | Educational Measurement | 2 | 2020 | 257 | 1.150 |
Why?
| | Uterine Neoplasms | 9 | 2010 | 73 | 1.140 |
Why?
| | Portal Vein | 4 | 2016 | 76 | 1.000 |
Why?
| | Microspheres | 29 | 2013 | 123 | 0.940 |
Why?
| | Treatment Outcome | 66 | 2019 | 9105 | 0.920 |
Why?
| | Practice Patterns, Physicians' | 8 | 2020 | 1177 | 0.910 |
Why?
| | Venous Thrombosis | 5 | 2017 | 142 | 0.900 |
Why?
| | Vena Cava, Inferior | 5 | 2018 | 56 | 0.900 |
Why?
| | Prosthesis Design | 6 | 2017 | 285 | 0.900 |
Why?
| | Magnetic Resonance Imaging, Interventional | 8 | 2014 | 20 | 0.870 |
Why?
| | Specialty Boards | 2 | 2020 | 34 | 0.860 |
Why?
| | Total Disc Replacement | 2 | 2020 | 14 | 0.840 |
Why?
| | Intervertebral Disc | 3 | 2020 | 37 | 0.820 |
Why?
| | Uterus | 6 | 2007 | 193 | 0.780 |
Why?
| | Venous Insufficiency | 3 | 2007 | 11 | 0.770 |
Why?
| | Leiomyoma | 7 | 2007 | 45 | 0.760 |
Why?
| | Saphenous Vein | 3 | 2007 | 31 | 0.750 |
Why?
| | Thromboembolism | 3 | 2017 | 94 | 0.750 |
Why?
| | Postoperative Complications | 5 | 2020 | 2132 | 0.730 |
Why?
| | Laser Therapy | 3 | 2007 | 100 | 0.700 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2020 | 28 | 0.690 |
Why?
| | Prosthesis Implantation | 3 | 2017 | 139 | 0.680 |
Why?
| | Intervertebral Disc Displacement | 1 | 2020 | 36 | 0.670 |
Why?
| | Middle Aged | 78 | 2019 | 26801 | 0.650 |
Why?
| | Venous Thromboembolism | 4 | 2017 | 231 | 0.640 |
Why?
| | Graft Occlusion, Vascular | 2 | 2018 | 35 | 0.630 |
Why?
| | Magnetic Resonance Angiography | 10 | 2014 | 221 | 0.630 |
Why?
| | Endovascular Procedures | 4 | 2020 | 268 | 0.630 |
Why?
| | Low Back Pain | 1 | 2020 | 95 | 0.620 |
Why?
| | Ultrasonography, Interventional | 3 | 2016 | 123 | 0.610 |
Why?
| | Humans | 133 | 2020 | 114925 | 0.600 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 15 | 0.600 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2019 | 180 | 0.600 |
Why?
| | Magnetic Resonance Imaging | 25 | 2015 | 3053 | 0.590 |
Why?
| | Spine | 1 | 2019 | 136 | 0.590 |
Why?
| | Aged | 60 | 2018 | 19120 | 0.580 |
Why?
| | Ascites | 2 | 2016 | 33 | 0.570 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 63 | 0.560 |
Why?
| | Spinal Fusion | 2 | 2019 | 210 | 0.560 |
Why?
| | Stents | 8 | 2015 | 476 | 0.560 |
Why?
| | Time Factors | 23 | 2020 | 6125 | 0.550 |
Why?
| | Tomography, X-Ray Computed | 23 | 2018 | 2326 | 0.550 |
Why?
| | Orthopedic Procedures | 1 | 2019 | 208 | 0.540 |
Why?
| | Female | 93 | 2019 | 59571 | 0.530 |
Why?
| | Aged, 80 and over | 32 | 2018 | 6363 | 0.530 |
Why?
| | Esophageal and Gastric Varices | 1 | 2016 | 31 | 0.520 |
Why?
| | Brachytherapy | 8 | 2008 | 104 | 0.510 |
Why?
| | Digestive System Neoplasms | 1 | 2015 | 8 | 0.510 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2016 | 29 | 0.510 |
Why?
| | Male | 81 | 2020 | 55655 | 0.490 |
Why?
| | Social Media | 1 | 2017 | 133 | 0.490 |
Why?
| | Diagnostic Imaging | 3 | 2017 | 290 | 0.490 |
Why?
| | Cholestasis | 2 | 2015 | 224 | 0.480 |
Why?
| | Adult | 54 | 2020 | 30604 | 0.480 |
Why?
| | Retrospective Studies | 32 | 2019 | 12543 | 0.470 |
Why?
| | Renal Dialysis | 1 | 2018 | 369 | 0.470 |
Why?
| | Clinical Competence | 2 | 2019 | 901 | 0.450 |
Why?
| | Imaging, Three-Dimensional | 5 | 2011 | 517 | 0.390 |
Why?
| | Liver Cirrhosis | 6 | 2019 | 228 | 0.390 |
Why?
| | Angiography | 11 | 2011 | 176 | 0.390 |
Why?
| | Risk Factors | 17 | 2017 | 8637 | 0.380 |
Why?
| | Cholangiocarcinoma | 4 | 2013 | 38 | 0.370 |
Why?
| | Uterine Artery Embolization | 1 | 2010 | 6 | 0.350 |
Why?
| | Drainage | 3 | 2019 | 151 | 0.350 |
Why?
| | Vascular System Injuries | 3 | 2016 | 64 | 0.350 |
Why?
| | Perfusion Imaging | 1 | 2010 | 51 | 0.350 |
Why?
| | Chicago | 6 | 2017 | 45 | 0.340 |
Why?
| | Adenoma, Islet Cell | 1 | 2009 | 10 | 0.340 |
Why?
| | Liver Abscess | 1 | 2009 | 5 | 0.340 |
Why?
| | Observer Variation | 3 | 2010 | 297 | 0.330 |
Why?
| | Thyroid Gland | 1 | 2009 | 84 | 0.330 |
Why?
| | Polyvinyl Alcohol | 3 | 2005 | 13 | 0.330 |
Why?
| | Contrast Media | 12 | 2016 | 353 | 0.320 |
Why?
| | Hepatic Veins | 1 | 2008 | 29 | 0.320 |
Why?
| | Phlebography | 6 | 2015 | 35 | 0.310 |
Why?
| | Pancreatic Neoplasms | 3 | 2010 | 733 | 0.310 |
Why?
| | Databases, Factual | 7 | 2020 | 1125 | 0.310 |
Why?
| | Predictive Value of Tests | 10 | 2015 | 1801 | 0.310 |
Why?
| | Gelatin | 2 | 2005 | 36 | 0.310 |
Why?
| | Portography | 4 | 2016 | 11 | 0.300 |
Why?
| | Neovascularization, Pathologic | 5 | 2009 | 283 | 0.300 |
Why?
| | Liver Transplantation | 5 | 2015 | 706 | 0.300 |
Why?
| | Referral and Consultation | 1 | 2012 | 634 | 0.300 |
Why?
| | Radiation Dosage | 5 | 2016 | 136 | 0.290 |
Why?
| | Antineoplastic Agents | 6 | 2014 | 1897 | 0.290 |
Why?
| | Lymphangioma, Cystic | 1 | 2007 | 4 | 0.290 |
Why?
| | Bile Duct Neoplasms | 4 | 2013 | 56 | 0.290 |
Why?
| | Catheterization | 7 | 2013 | 160 | 0.280 |
Why?
| | Prosthesis Failure | 3 | 2017 | 117 | 0.280 |
Why?
| | Aortography | 1 | 2007 | 50 | 0.280 |
Why?
| | Angioplasty | 1 | 2007 | 40 | 0.280 |
Why?
| | United States | 10 | 2020 | 12209 | 0.280 |
Why?
| | Hepatic Artery | 5 | 2010 | 48 | 0.280 |
Why?
| | Neoplasms | 4 | 2017 | 2106 | 0.280 |
Why?
| | Rabbits | 11 | 2013 | 748 | 0.270 |
Why?
| | Thyroid Neoplasms | 1 | 2009 | 263 | 0.270 |
Why?
| | Linear Models | 4 | 2017 | 770 | 0.270 |
Why?
| | Thrombosis | 3 | 1998 | 297 | 0.270 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2007 | 113 | 0.260 |
Why?
| | Acrylic Resins | 1 | 2005 | 38 | 0.260 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2007 | 182 | 0.250 |
Why?
| | Radiation Injuries | 5 | 2010 | 128 | 0.250 |
Why?
| | Radiology | 1 | 2008 | 193 | 0.250 |
Why?
| | Internship and Residency | 2 | 2019 | 944 | 0.250 |
Why?
| | Survival Rate | 12 | 2018 | 1644 | 0.240 |
Why?
| | Ovary | 2 | 2003 | 191 | 0.240 |
Why?
| | Blister | 1 | 2004 | 43 | 0.230 |
Why?
| | Liver Neoplasms, Experimental | 3 | 2008 | 26 | 0.230 |
Why?
| | Arteries | 7 | 2013 | 247 | 0.230 |
Why?
| | Multivariate Analysis | 7 | 2017 | 1440 | 0.230 |
Why?
| | Medicare | 2 | 2020 | 666 | 0.230 |
Why?
| | Logistic Models | 6 | 2019 | 1843 | 0.220 |
Why?
| | Jugular Veins | 3 | 1997 | 37 | 0.210 |
Why?
| | Neoplasm Staging | 8 | 2014 | 1180 | 0.210 |
Why?
| | Clinical Trials as Topic | 3 | 2013 | 934 | 0.200 |
Why?
| | Disease Progression | 14 | 2014 | 2392 | 0.200 |
Why?
| | Fluoroscopy | 2 | 2016 | 139 | 0.200 |
Why?
| | Liver | 7 | 2013 | 1634 | 0.200 |
Why?
| | Education, Medical, Continuing | 2 | 2017 | 119 | 0.200 |
Why?
| | Kaplan-Meier Estimate | 9 | 2015 | 817 | 0.200 |
Why?
| | Neoplasms, Experimental | 2 | 2013 | 152 | 0.200 |
Why?
| | Disease Models, Animal | 6 | 2016 | 3549 | 0.190 |
Why?
| | Chi-Square Distribution | 6 | 2014 | 495 | 0.190 |
Why?
| | Reoperation | 4 | 2019 | 515 | 0.190 |
Why?
| | Constriction, Pathologic | 3 | 2019 | 209 | 0.190 |
Why?
| | Medical Oncology | 2 | 2013 | 228 | 0.190 |
Why?
| | Vascular Patency | 3 | 2018 | 97 | 0.190 |
Why?
| | Angiography, Digital Subtraction | 6 | 2014 | 43 | 0.190 |
Why?
| | Catheter Ablation | 1 | 2004 | 291 | 0.190 |
Why?
| | Liver Diseases | 2 | 2007 | 254 | 0.190 |
Why?
| | alpha-Fetoproteins | 2 | 2012 | 31 | 0.180 |
Why?
| | Sensitivity and Specificity | 9 | 2012 | 1700 | 0.180 |
Why?
| | Surgical Stomas | 1 | 2000 | 6 | 0.180 |
Why?
| | Colostomy | 1 | 2000 | 26 | 0.180 |
Why?
| | Varicose Veins | 1 | 2000 | 14 | 0.180 |
Why?
| | Thrombolytic Therapy | 2 | 1998 | 117 | 0.180 |
Why?
| | Infusions, Intra-Arterial | 9 | 2010 | 46 | 0.180 |
Why?
| | Lumbosacral Region | 1 | 2020 | 46 | 0.170 |
Why?
| | Hepatorenal Syndrome | 1 | 2019 | 14 | 0.170 |
Why?
| | Budd-Chiari Syndrome | 1 | 1999 | 6 | 0.170 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2000 | 102 | 0.170 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2011 | 224 | 0.170 |
Why?
| | Laminoplasty | 1 | 2019 | 1 | 0.170 |
Why?
| | Follow-Up Studies | 10 | 2013 | 4427 | 0.170 |
Why?
| | Prospective Studies | 13 | 2014 | 6218 | 0.170 |
Why?
| | Laminectomy | 1 | 2019 | 25 | 0.160 |
Why?
| | Specialization | 1 | 2020 | 115 | 0.160 |
Why?
| | Iliac Artery | 2 | 2018 | 44 | 0.160 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2010 | 83 | 0.160 |
Why?
| | Ohio | 1 | 2019 | 135 | 0.160 |
Why?
| | Bile Ducts | 1 | 2019 | 68 | 0.160 |
Why?
| | Glass | 3 | 2013 | 42 | 0.160 |
Why?
| | Young Adult | 7 | 2018 | 10476 | 0.160 |
Why?
| | Survival Analysis | 6 | 2011 | 1220 | 0.160 |
Why?
| | Models, Educational | 1 | 2019 | 85 | 0.160 |
Why?
| | Patient Selection | 5 | 2015 | 642 | 0.160 |
Why?
| | Mesenteric Veins | 1 | 1998 | 9 | 0.150 |
Why?
| | Intestine, Small | 1 | 2019 | 122 | 0.150 |
Why?
| | Biliary Fistula | 1 | 1998 | 3 | 0.150 |
Why?
| | Urinary Fistula | 1 | 1998 | 9 | 0.150 |
Why?
| | Thrombectomy | 1 | 1998 | 52 | 0.150 |
Why?
| | Catheters | 2 | 2015 | 65 | 0.150 |
Why?
| | Writing | 1 | 2019 | 85 | 0.150 |
Why?
| | Pain | 1 | 2003 | 710 | 0.150 |
Why?
| | Liver Circulation | 4 | 2015 | 19 | 0.140 |
Why?
| | Patient Advocacy | 1 | 2017 | 66 | 0.140 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2019 | 204 | 0.140 |
Why?
| | Treatment Failure | 4 | 2017 | 332 | 0.140 |
Why?
| | Radiography | 7 | 2012 | 819 | 0.140 |
Why?
| | Cell Line, Tumor | 7 | 2013 | 2725 | 0.140 |
Why?
| | Research Design | 3 | 2013 | 932 | 0.140 |
Why?
| | Lower Extremity | 1 | 2020 | 335 | 0.140 |
Why?
| | Ultrasonography, Doppler, Color | 2 | 2008 | 33 | 0.140 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 19 | 0.140 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 172 | 0.140 |
Why?
| | Drug Utilization | 1 | 2017 | 167 | 0.140 |
Why?
| | History, 20th Century | 1 | 2017 | 267 | 0.130 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 21 | 0.130 |
Why?
| | Doxorubicin | 3 | 2013 | 286 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2019 | 415 | 0.130 |
Why?
| | Portal Pressure | 1 | 2016 | 4 | 0.130 |
Why?
| | Reproducibility of Results | 8 | 2011 | 2769 | 0.130 |
Why?
| | Balloon Occlusion | 1 | 2016 | 26 | 0.130 |
Why?
| | Adolescent | 14 | 2018 | 17826 | 0.130 |
Why?
| | Gadolinium DTPA | 5 | 2014 | 47 | 0.130 |
Why?
| | Anatomic Landmarks | 1 | 2016 | 23 | 0.130 |
Why?
| | Wounds, Nonpenetrating | 4 | 2000 | 225 | 0.130 |
Why?
| | Finite Element Analysis | 1 | 2016 | 66 | 0.130 |
Why?
| | Operative Time | 1 | 2016 | 106 | 0.130 |
Why?
| | Radiation Exposure | 1 | 2016 | 40 | 0.130 |
Why?
| | Sex Factors | 2 | 2018 | 1721 | 0.130 |
Why?
| | Stomach | 2 | 2013 | 101 | 0.130 |
Why?
| | Hospital Mortality | 2 | 2018 | 776 | 0.130 |
Why?
| | Aorta | 1 | 2018 | 390 | 0.130 |
Why?
| | Models, Anatomic | 1 | 2016 | 87 | 0.130 |
Why?
| | Length of Stay | 2 | 2019 | 949 | 0.130 |
Why?
| | Bile Ducts, Intrahepatic | 3 | 2013 | 47 | 0.120 |
Why?
| | Intraoperative Complications | 1 | 2016 | 122 | 0.120 |
Why?
| | Cisplatin | 3 | 2012 | 263 | 0.120 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 374 | 0.120 |
Why?
| | Dilatation | 1 | 2015 | 60 | 0.120 |
Why?
| | Wounds, Gunshot | 1 | 1998 | 188 | 0.120 |
Why?
| | Biopsy | 3 | 2014 | 1045 | 0.120 |
Why?
| | Data Interpretation, Statistical | 3 | 2013 | 323 | 0.120 |
Why?
| | End Stage Liver Disease | 1 | 2015 | 63 | 0.120 |
Why?
| | Carotid Artery Injuries | 3 | 2000 | 43 | 0.120 |
Why?
| | Carbon Dioxide | 1 | 2016 | 218 | 0.120 |
Why?
| | Kidney Diseases | 1 | 1998 | 350 | 0.120 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 37 | 0.110 |
Why?
| | Anticoagulants | 2 | 2017 | 547 | 0.110 |
Why?
| | Peripheral Arterial Disease | 1 | 2020 | 380 | 0.110 |
Why?
| | Stress, Mechanical | 1 | 2016 | 447 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1361 | 0.110 |
Why?
| | Arthroscopy | 3 | 1992 | 200 | 0.110 |
Why?
| | Magnetite Nanoparticles | 1 | 2013 | 28 | 0.110 |
Why?
| | Duodenum | 1 | 2013 | 62 | 0.110 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 671 | 0.110 |
Why?
| | Patient Education as Topic | 1 | 2017 | 678 | 0.110 |
Why?
| | Proportional Hazards Models | 5 | 2014 | 1080 | 0.110 |
Why?
| | Catheterization, Peripheral | 3 | 2008 | 102 | 0.100 |
Why?
| | Shoulder Injuries | 1 | 1992 | 52 | 0.100 |
Why?
| | Acromion | 1 | 1992 | 7 | 0.100 |
Why?
| | Fibrin | 1 | 2012 | 65 | 0.100 |
Why?
| | Electroporation | 1 | 2012 | 31 | 0.100 |
Why?
| | Fibromuscular Dysplasia | 1 | 2011 | 4 | 0.100 |
Why?
| | Prognosis | 5 | 2010 | 3344 | 0.100 |
Why?
| | Rotator Cuff | 1 | 1992 | 43 | 0.100 |
Why?
| | Tendon Injuries | 1 | 1992 | 75 | 0.100 |
Why?
| | Respiratory-Gated Imaging Techniques | 1 | 2011 | 10 | 0.100 |
Why?
| | Comorbidity | 1 | 2016 | 1458 | 0.090 |
Why?
| | Biomarkers, Tumor | 3 | 2012 | 1054 | 0.090 |
Why?
| | Neuroendocrine Tumors | 1 | 2011 | 85 | 0.090 |
Why?
| | Yttrium | 1 | 2010 | 5 | 0.090 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 63 | 0.090 |
Why?
| | Research Report | 1 | 2011 | 75 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2014 | 352 | 0.090 |
Why?
| | Injections, Intra-Arterial | 5 | 2012 | 25 | 0.090 |
Why?
| | Punctures | 1 | 2010 | 36 | 0.090 |
Why?
| | Gastrostomy | 2 | 2009 | 89 | 0.090 |
Why?
| | Breast Neoplasms | 2 | 2014 | 1870 | 0.090 |
Why?
| | Biopsy, Fine-Needle | 1 | 2009 | 64 | 0.080 |
Why?
| | Cohort Studies | 4 | 2018 | 4903 | 0.080 |
Why?
| | Practice Guidelines as Topic | 4 | 2013 | 1400 | 0.080 |
Why?
| | Palliative Care | 1 | 2015 | 639 | 0.080 |
Why?
| | Prevalence | 2 | 2012 | 2251 | 0.080 |
Why?
| | Pancreatic Pseudocyst | 1 | 2009 | 13 | 0.080 |
Why?
| | Necrosis | 4 | 2010 | 210 | 0.080 |
Why?
| | Bilirubin | 3 | 2010 | 88 | 0.080 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 213 | 0.080 |
Why?
| | Animals | 13 | 2016 | 31837 | 0.080 |
Why?
| | Radiation Pneumonitis | 1 | 2008 | 26 | 0.080 |
Why?
| | Liver Function Tests | 3 | 2015 | 103 | 0.080 |
Why?
| | Radiotherapy Dosage | 4 | 2010 | 245 | 0.080 |
Why?
| | Biliary Tract | 1 | 2008 | 16 | 0.080 |
Why?
| | Knee Injuries | 1 | 1989 | 89 | 0.080 |
Why?
| | Maximum Allowable Concentration | 1 | 2007 | 14 | 0.080 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 1355 | 0.070 |
Why?
| | Subtraction Technique | 1 | 2007 | 24 | 0.070 |
Why?
| | Incidence | 3 | 2009 | 2316 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 232 | 0.070 |
Why?
| | Endpoint Determination | 3 | 2013 | 69 | 0.070 |
Why?
| | Diagnostic Errors | 1 | 2008 | 151 | 0.070 |
Why?
| | Ultrasonography | 2 | 2015 | 633 | 0.070 |
Why?
| | Vacuum Curettage | 1 | 2007 | 5 | 0.070 |
Why?
| | Catheterization, Central Venous | 2 | 1999 | 81 | 0.070 |
Why?
| | Image Enhancement | 4 | 2011 | 162 | 0.070 |
Why?
| | Iron | 1 | 2008 | 233 | 0.070 |
Why?
| | Radiotherapy | 1 | 2008 | 176 | 0.070 |
Why?
| | Credentialing | 1 | 2006 | 12 | 0.070 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 249 | 0.070 |
Why?
| | Leiomyomatosis | 1 | 2006 | 1 | 0.070 |
Why?
| | Knee Joint | 1 | 1989 | 323 | 0.070 |
Why?
| | Quality Assurance, Health Care | 1 | 2008 | 313 | 0.070 |
Why?
| | Decision Making | 1 | 2012 | 782 | 0.070 |
Why?
| | Personnel Selection | 1 | 2006 | 63 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 300 | 0.060 |
Why?
| | Ethics, Research | 1 | 2005 | 33 | 0.060 |
Why?
| | Heart Failure | 1 | 2018 | 1952 | 0.060 |
Why?
| | Regional Blood Flow | 2 | 2007 | 424 | 0.060 |
Why?
| | Kidney Transplantation | 1 | 2011 | 542 | 0.060 |
Why?
| | Organ Size | 3 | 2013 | 435 | 0.060 |
Why?
| | Postmenopause | 1 | 2007 | 303 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1126 | 0.060 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2004 | 39 | 0.060 |
Why?
| | Pilot Projects | 4 | 2009 | 1372 | 0.060 |
Why?
| | Odds Ratio | 2 | 2017 | 954 | 0.060 |
Why?
| | Dose-Response Relationship, Radiation | 3 | 2008 | 128 | 0.060 |
Why?
| | Fellowships and Scholarships | 1 | 2006 | 227 | 0.060 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2003 | 9 | 0.060 |
Why?
| | Ischemia | 1 | 2006 | 362 | 0.050 |
Why?
| | Illinois | 3 | 2009 | 37 | 0.050 |
Why?
| | Hepatectomy | 2 | 2013 | 119 | 0.050 |
Why?
| | Menisci, Tibial | 2 | 1995 | 53 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2009 | 621 | 0.050 |
Why?
| | Aneurysm, False | 2 | 2000 | 45 | 0.050 |
Why?
| | Feasibility Studies | 3 | 2011 | 737 | 0.050 |
Why?
| | Drug Stability | 2 | 2013 | 151 | 0.050 |
Why?
| | Tumor Burden | 2 | 2014 | 262 | 0.050 |
Why?
| | Confidence Intervals | 2 | 2013 | 309 | 0.050 |
Why?
| | World Health Organization | 2 | 2012 | 103 | 0.050 |
Why?
| | Recurrence | 2 | 2000 | 937 | 0.040 |
Why?
| | Europe | 2 | 2012 | 336 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 21 | 0.040 |
Why?
| | Carotid Artery, Internal | 1 | 2000 | 36 | 0.040 |
Why?
| | Hospitalization | 2 | 2020 | 1754 | 0.040 |
Why?
| | Disease-Free Survival | 2 | 2013 | 623 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 40 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 39 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 48 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2000 | 108 | 0.040 |
Why?
| | Hepatic Encephalopathy | 1 | 1999 | 19 | 0.040 |
Why?
| | Evidence-Based Medicine | 2 | 2013 | 675 | 0.040 |
Why?
| | Liver Failure | 1 | 1999 | 75 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 136 | 0.040 |
Why?
| | Tomography, Emission-Computed | 2 | 2009 | 58 | 0.040 |
Why?
| | Tracheoesophageal Fistula | 1 | 1999 | 32 | 0.040 |
Why?
| | Postoperative Hemorrhage | 1 | 1999 | 75 | 0.040 |
Why?
| | Serum Albumin | 1 | 1999 | 134 | 0.040 |
Why?
| | Streptokinase | 1 | 1998 | 10 | 0.040 |
Why?
| | Multiple Organ Failure | 1 | 1999 | 142 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2011 | 1227 | 0.040 |
Why?
| | Swine | 2 | 2016 | 701 | 0.040 |
Why?
| | Equipment Design | 2 | 2012 | 511 | 0.040 |
Why?
| | Ethiodized Oil | 2 | 2008 | 5 | 0.040 |
Why?
| | Mitomycin | 2 | 2008 | 27 | 0.040 |
Why?
| | Guidelines as Topic | 2 | 2010 | 244 | 0.040 |
Why?
| | Nervous System Diseases | 2 | 2017 | 252 | 0.040 |
Why?
| | Cause of Death | 1 | 1999 | 363 | 0.040 |
Why?
| | Cartilage Diseases | 2 | 1995 | 40 | 0.040 |
Why?
| | Intracranial Hypertension | 1 | 1997 | 38 | 0.040 |
Why?
| | Abdominal Injuries | 1 | 1998 | 95 | 0.030 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1997 | 117 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 162 | 0.030 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1997 | 112 | 0.030 |
Why?
| | Demography | 1 | 2017 | 262 | 0.030 |
Why?
| | Positron-Emission Tomography | 2 | 2008 | 265 | 0.030 |
Why?
| | Acute Disease | 1 | 1999 | 915 | 0.030 |
Why?
| | Recovery of Function | 1 | 2000 | 572 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 479 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2003 | 3008 | 0.030 |
Why?
| | Databases as Topic | 2 | 2010 | 63 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 237 | 0.030 |
Why?
| | Lung | 1 | 2008 | 3593 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 380 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 233 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 178 | 0.030 |
Why?
| | Phantoms, Imaging | 2 | 2008 | 122 | 0.030 |
Why?
| | Cysts | 1 | 1995 | 93 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 479 | 0.030 |
Why?
| | Preoperative Care | 1 | 2016 | 317 | 0.030 |
Why?
| | Embolism | 2 | 2008 | 43 | 0.030 |
Why?
| | Vascular Surgical Procedures | 1 | 2016 | 257 | 0.030 |
Why?
| | Ablation Techniques | 1 | 2013 | 29 | 0.030 |
Why?
| | Eligibility Determination | 1 | 2013 | 60 | 0.030 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2013 | 182 | 0.030 |
Why?
| | Scapula | 1 | 1992 | 40 | 0.030 |
Why?
| | Biomarkers | 2 | 2014 | 3418 | 0.030 |
Why?
| | Nausea | 1 | 2011 | 104 | 0.020 |
Why?
| | Muscular Diseases | 1 | 1992 | 105 | 0.020 |
Why?
| | Vomiting | 1 | 2011 | 124 | 0.020 |
Why?
| | Neoadjuvant Therapy | 1 | 2013 | 305 | 0.020 |
Why?
| | International Agencies | 1 | 2010 | 29 | 0.020 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2010 | 59 | 0.020 |
Why?
| | Diarrhea | 1 | 2011 | 173 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2011 | 136 | 0.020 |
Why?
| | Risk Assessment | 2 | 2009 | 2975 | 0.020 |
Why?
| | Registries | 1 | 2018 | 1760 | 0.020 |
Why?
| | Standard of Care | 1 | 2010 | 62 | 0.020 |
Why?
| | Yttrium Isotopes | 1 | 2009 | 1 | 0.020 |
Why?
| | Fatigue | 1 | 2011 | 296 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 2891 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 1593 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 187 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2010 | 143 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 292 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 1992 | 355 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 448 | 0.020 |
Why?
| | Fibula | 1 | 1989 | 41 | 0.020 |
Why?
| | Ligaments, Articular | 1 | 1989 | 56 | 0.020 |
Why?
| | Rhenium | 1 | 2008 | 4 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2211 | 0.020 |
Why?
| | Radioisotopes | 1 | 2008 | 28 | 0.020 |
Why?
| | Iohexol | 1 | 2008 | 17 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2008 | 285 | 0.020 |
Why?
| | Body Burden | 1 | 2007 | 5 | 0.020 |
Why?
| | Femur | 1 | 1989 | 191 | 0.020 |
Why?
| | Hysterosalpingography | 1 | 2007 | 6 | 0.020 |
Why?
| | Tibia | 1 | 1989 | 166 | 0.020 |
Why?
| | Regression Analysis | 1 | 2010 | 947 | 0.020 |
Why?
| | Hindlimb | 1 | 2008 | 130 | 0.020 |
Why?
| | Injections | 1 | 2008 | 159 | 0.020 |
Why?
| | Celiac Artery | 1 | 2007 | 9 | 0.020 |
Why?
| | Mesenteric Arteries | 1 | 2007 | 16 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2007 | 133 | 0.020 |
Why?
| | Weight Loss | 1 | 2011 | 642 | 0.020 |
Why?
| | Contraindications | 1 | 2007 | 85 | 0.020 |
Why?
| | Injury Severity Score | 2 | 2000 | 457 | 0.020 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 101 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 855 | 0.020 |
Why?
| | Cartilage, Articular | 1 | 1989 | 289 | 0.020 |
Why?
| | Retreatment | 1 | 2005 | 67 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1215 | 0.020 |
Why?
| | Rats | 1 | 2013 | 4963 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2007 | 530 | 0.020 |
Why?
| | Algorithms | 1 | 2011 | 1474 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 9083 | 0.010 |
Why?
| | Child | 3 | 2017 | 18362 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2002 | 387 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 346 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 82 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 2000 | 39 | 0.010 |
Why?
| | Pneumonia, Aspiration | 1 | 1999 | 15 | 0.010 |
Why?
| | Hematoma | 1 | 1999 | 50 | 0.010 |
Why?
| | Veins | 1 | 1999 | 56 | 0.010 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 53 | 0.010 |
Why?
| | Esophageal Stenosis | 1 | 1999 | 44 | 0.010 |
Why?
| | Decision Trees | 1 | 1998 | 80 | 0.010 |
Why?
| | Aortic Diseases | 1 | 2000 | 109 | 0.010 |
Why?
| | Arm | 1 | 1999 | 104 | 0.010 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1999 | 121 | 0.010 |
Why?
| | Cerebral Infarction | 1 | 1997 | 39 | 0.010 |
Why?
| | Los Angeles | 1 | 1997 | 56 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1997 | 65 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 157 | 0.010 |
Why?
| | Carotid Artery Diseases | 1 | 1997 | 57 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1997 | 114 | 0.010 |
Why?
| | Glasgow Coma Scale | 1 | 1997 | 144 | 0.010 |
Why?
| | Intracranial Pressure | 1 | 1997 | 47 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1998 | 232 | 0.010 |
Why?
| | Multiple Trauma | 1 | 1997 | 89 | 0.010 |
Why?
| | Carotid Stenosis | 1 | 1997 | 79 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1997 | 89 | 0.010 |
Why?
| | Heparin | 1 | 1997 | 222 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1997 | 180 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 1997 | 128 | 0.010 |
Why?
| | HIV | 1 | 1997 | 208 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1997 | 310 | 0.010 |
Why?
| | Cluster Analysis | 1 | 1997 | 460 | 0.010 |
Why?
| | Synovial Cyst | 1 | 1995 | 2 | 0.010 |
Why?
| | DNA, Viral | 1 | 1997 | 350 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1997 | 268 | 0.010 |
Why?
| | Brain Ischemia | 1 | 1997 | 299 | 0.010 |
Why?
| | Brain Injuries | 1 | 1997 | 452 | 0.010 |
Why?
| | Tibial Meniscus Injuries | 1 | 1990 | 43 | 0.010 |
Why?
| | Postoperative Period | 1 | 1990 | 289 | 0.010 |
Why?
|
|
Ryu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|